anti-Human HLA-DR Conjugated to Fluophore 423
| Catalog number: | B2016071 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 50 ug |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Violet 423 anti-human HLA-DR |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Park KH, Sawada T, Murakami T, Ishii Y, Yasuo M, Urakawa M, Aoyagi Y, Fuchinoue S, Kubota K. Anti-human leukocyte antigen-DR (MHC class II) humanized monoclonal antibody, IMMU-114, suppresses human to bovine cellular responses J Surg Res. 2012 Nov;178(1):472-7.
- Al Saati T, Laurent G, Caveriviere P, Rigal F, Delsol G. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers) Clin Exp Immunol. 1984 Dec;58(3):631-8.
- Mostbck S, Wu HH, Fenn T, Riegler B, Strahlhofer S, Huang Y, Hansen G, Kroe-Barrett R, Tirapu I, Vogt AB. Distinct immune stimulatory effects of anti-human VISTA antibodies are determined by Fc-receptor interaction Front Immunol. 2022 Jul 28;13:862757.
- Carta P, Di Maria L, Caroti L, Buti E, Antognoli G, Minetti EE. Anti-human leukocyte antigen DQ antibodies in renal transplantation: Are we underestimating the most frequent donor specific alloantibodies? Transplant Rev (Orlando). 2015 Jul;29(3):135-8.
- Kim B, Kim S, Park Y, Kim HS. False-positive reactivity of anti-human leukocyte antigen antibodies detected using the single-antigen bead assay Hum Immunol. 2021 Jun;82(6):409-413.
- Laub R, Brecht R, Dorsch M, Valey U, Wenk K, Emmrich F. Anti-human CD4 induces peripheral tolerance in a human CD4+, murine CD4-, HLA-DR+ advanced transgenic mouse model J Immunol. 2002 Sep 15;169(6):2947-55.
- Eleftheriadis T, Pissas G, Crespo M, Filippidis G, Antoniadis N, Liakopoulos V, Stefanidis I. The effect of antiHLA class I antibodies on the immunological properties of human glomerular endothelial cells and their modification by mTOR inhibition or GCN2 kinase activation Mol Med Rep. 2021 May;23(5):355.
- Stein R, Balkman C, Chen S, Rassnick K, McEntee M, Page R, Goldenberg DM. Evaluation of anti-human leukocyte antigen-DR monoclonal antibody therapy in spontaneous canine lymphoma Leuk Lymphoma. 2011 Feb;52(2):273-84.
- Rebai N, Malissen B, Pierres M, Accolla RS, Corte G, Mawas C. Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb Eur J Immunol. 1983 Feb;13(2):106-11.
